FUSED PROTEINS IL-7 Russian patent published in 2009 - IPC C07K14/54 C12N15/62 A61K38/04 

Abstract RU 2369616 C2

FIELD: medicine.

SUBSTANCE: there is provided fused protein, including immunoglobulin chain and the molecule IL-7 or its fragment, displaying activity typical to IL-7, that is modified in comparison with IL-7 of wild type, where modification in IL-7 represents amino-acid residues in positions 70 and 91, that are glycated, and amino-acid residue in the position 116 is nonglycated. There is proposed pharmaceutical composition, containing described protein. There is provided the method fro production of described fused protein, including: host cell transformation by DNA, coding specified fused protein IL-7, host cell culture and collection of fused protein IL-7.

EFFECT: invention can be applied for treatment of disorders, accompanied by immune deficiencies.

27 cl, 16 dwg, 1 tbl, 10 ex

Similar patents RU2369616C2

Title Year Author Number
FUSED PROTEIN ELICITING BIOLOGICAL ACTIVITY OF INTERFERON-ALPHA, DIMERIC FUSED PROTEIN, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF, DNA MOLECULE (VARIANTS) AND METHOD FOR TARGETING INTERFERON-ALPHA INTO LIVER TISSUE 2000
  • Sun Japing
  • Dzhilliz Stefen D.
  • Lo Kin-Ming
RU2262510C9
HOMODIMERIC FUSED PROTEIN WITH ACTIVITY OF ANGIOGENESIS INHIBITOR (VARIANTS), DNA MOLECULE ENCODING HOMODIMERIC FUSED PROTEIN, VECTOR FOR EXPRESSION OF HOMODIMERIC FUSED PROTEIN, METHOD FOR TRANSFECTION OF MAMMALIAN CELL AND METHOD FOR PREPARING HOMODIMERIC FUSED PROTEIN 1999
  • Lo Kin-Ming
  • Li Jue
  • Dzhilliz Stefen D.
RU2240328C2
IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS 2008
  • Karrer Ehrik E.
  • Pejdkhungat Madan M.
  • Bejs Stiven Kh.
  • Nejbors Margaret
  • Punnonen Jukha
  • Chepin Stiven Dzh.
  • Visvanatkhan Sridkhar
  • Larsen Brent R.
RU2506275C2
HETERODIMERIC IL-15 PROTEIN AND USE THEREOF 2014
  • Tsyuj Syandun
  • E Sin
  • Yuan Tszitszyun
  • Chzhan Lej
  • Chen Kan
  • Chzhan Lyanshan
  • Tsao Gotsin
  • Syuj Chzhibin
  • Tao Vejkan
RU2689717C2
HUMANISED ANTIBODY (H14,18) BASED ON MOUSE ANTIBODY 14,18, CONTACTING GD2, AND ITS FUSION WITH IL-2 2003
  • Dzhilliz Stefen D.
  • Lo Kin Ming
RU2366664C2
FUSED IMMUNOGLOBULIN PROTEINS 2008
  • Sung,Joung Chul
  • Jang,Sekhvan
RU2530168C2
SINGLE-STRANDED CD40 RECEPTOR AGONIST PROTEINS 2016
  • Hill, Oliver
  • Gieffers, Christian
  • Thiemann, Meinolf
  • Schnyder, Tim
RU2745801C2
ANTIBODY AGAINST IL-4R AND APPLICATION THEREOF 2018
  • Liu Zhigang
  • Liu Yulan
  • Hao Xiaobo
  • Jiang Lei
  • Guo Jingjing
RU2758091C1
POLYPEPTIDES AND POLYNUCLEOTIDES AND THEIR USE FOR TREATMENT OF IMMUNE DISORDERS AND CANCER 2012
  • Toporik Amir
  • Novik Amit
  • Shemesh Ronen
RU2623161C2
BIOLOGICALLY ACTIVATED DRUGS BASED ON CYTOKINES AND METHODS OF USING THEM 2019
  • Li Yue-Sheng
  • Rui Lingyun
  • Xu Jing
RU2819307C2

RU 2 369 616 C2

Authors

Loder Skott

Gillis Stiven D.

Dates

2009-10-10Published

2004-12-21Filed